Skip to content

Drug Wastage : Observational Study in the Operating Rooms of France

Drug Wastage : Observational Study in the Operating Rooms of France

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05609864
Acronym
GAME-OvBLOC
Enrollment
3763
Registered
2022-11-08
Start date
2023-04-06
Completion date
2023-07-20
Last updated
2026-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug Use

Keywords

Drug wastage, Green Anesthesia, Environmental sustainability, Injectable drugs, Eco-design of care, Operating Room

Brief summary

Environmental awareness is leading medical field to question its responsibility and possibilities for action. Drug residues can have a major environmental impact as per their bioaccumulation, toxicity and persistence characteristics, depending on where they are discarded. In France, drug residues should be disposed of by incineration, but in practice this is not systematic. Moreover, data on drug wastage in the operating rooms by anesthesia department are rare. The GAME-OvBLOC observational study aim to evaluate drug wastage in the operating rooms by anesthesia department in France and to propose ways of improving health care practices.

Detailed description

Observational study with data collection over a 24-hour business day. Data collected refer to healthcare team's practices and patients.

Interventions

OTHERQuantification of injectable drugs wastage

Drugs are prescribed at discretion of physicians. For each patient who have anesthesia in the operating room, all labelled syringes having contained drugs (name + dilution) are collected and analyzed.

Sponsors

Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Lead SponsorOTHER
Sainte-Anne Military Teaching Hospital
CollaboratorUNKNOWN

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* All patients who will need an anesthesia act in operating room during a 24 hours period

Exclusion criteria

* Patient opposition to participate in the study or parents opposition if the patient is a child or patient family opposition if the patient is not capable of being informed

Design outcomes

Primary

MeasureTime frameDescription
Ratio of overall wastage in milliliter (mL) of prepared and discarded injectable drugs, to overall volume in milliliter (mL) of prepared injectable drugs24 hoursWastage is defined as : any prepared and unused drug that remains in syringe

Secondary

MeasureTime frameDescription
Reason for discarding drug residues24 hoursThe reason of waste full syringe will be noticed : 1/ prepared in advance and not used ; 2/ prescription change ; 3/ preparation error ; 4/ other reason
Describe drug wastage for each kind of surgery/anesthesia24 hoursDrug wastage according to type of surgery and anaesthesia
Drug residues discarding process24 hoursQuestionnaire on nursing practices on the choice of waste disposal circuits according to drugs
Cost of overall injectable drugs wastage24 hoursEstimated cost of drug residues will be evaluated for each drug by the following formula : volume of discarded injectable drugs x theoretical price
Describe drug wastage for each age group24 hoursDrug wastage according to the following age groups : adult (≥18 years old) and pediatrics (\< 1 year old, 1-5 years old, ≥ 6 years old)
Describe waste and environmental impact of used plastic syringes24 hoursNumber and volume of used syringes, use of pre-filled syringes, refilling of syringes and multi-patient use. Environmental impact is indirectly assessed by type of plastic used and the transport distance from the production site to France.
Use of alternative to injectable drugs24 hoursAlternatives : local anaesthesia and anaesthetic gases

Countries

France, Guadeloupe, Mayotte, Monaco

Contacts

STUDY_DIRECTORErwan D'Aranda, MD

Sainte-Anne Military Teaching Hospital (Hôpital d'instruction des armées Sainte Anne)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 8, 2026